Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).

MLA

Cohn, J. B., and L. A. Gottschalk. “Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).” Methods and Findings in Experimental and Clinical Pharmacology, vol. 1, no. 5, Dec. 1979, pp. 313–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=45206&authtype=sso&custid=ns315887.

APA

Cohn, J. B., & Gottschalk, L. A. (1979). Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043). Methods and Findings in Experimental and Clinical Pharmacology, 1(5), 313–315.

Chicago

Cohn, J B, and L A Gottschalk. 1979. “Critique of the Guidelines for Clinical Evaluation of Antianxiety Drugs (HEW-FDA-77-3043).” Methods and Findings in Experimental and Clinical Pharmacology 1 (5): 313–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=45206&authtype=sso&custid=ns315887.